Full Library
ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
Resource type
Journal Article
Authors/contributors
- Warris, A. (Author)
- Lehrnbecher, T. (Author)
- Roilides, E. (Author)
- Castagnola, E. (Author)
- Brüggemann, R.J.M. (Author)
- Groll, A.H. (Author)
Title
ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
Abstract
Scope: Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer diagnostic tools, the pharmacology of antifungal agents and in the evidence from interventional phase 3 clinical trials. Therefore, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM) have developed a paediatric-specific guideline for the diagnosis and management of IA in neonates and children.
Publication
Clinical Microbiology and Infection
Date
09/2019
Volume
25
Issue
9
Pages
1096-1113
Journal Abbr
Clinical Microbiology and Infection
Accessed
5/16/23, 7:52 PM
ISSN
1198743X
Short Title
ESCMID-ECMM guideline
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Warris, A., Lehrnbecher, T., Roilides, E., Castagnola, E., Brüggemann, R. J. M., & Groll, A. H. (2019). ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clinical Microbiology and Infection, 25(9), 1096–1113. https://doi.org/10.1016/j.cmi.2019.05.019
GUIDELINES
ORGANISMS
Link to this record